Masamitsu Yanada

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications

Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis.

Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis.

Journal: Scientific reports
Published: March 16, 2026

Haploidentical transplantation versus umbilical cord blood transplantation in acute myeloid leukemia with measurable residual disease.

Haploidentical transplantation versus umbilical cord blood transplantation in acute myeloid leukemia with measurable residual disease.

Journal: Cytotherapy
Published: March 09, 2026

Maintenance Treatment With Gilteritinib Suppresses Post-transplant Relapse in Relapse/Refractory FLT3-Mutated Acute Myeloid Leukemia.

Maintenance Treatment With Gilteritinib Suppresses Post-transplant Relapse in Relapse/Refractory FLT3-Mutated Acute Myeloid Leukemia.

Journal: Transplantation and cellular therapy
Published: February 14, 2026

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 years.

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 years.

Journal: International journal of hematology
Published: January 17, 2026

Can Cord Blood Unit Selection Improve Outcomes After Single-Unit Unrelated Cord Blood Transplantation for Non-Remission Acute Myeloid Leukemia?

Can Cord Blood Unit Selection Improve Outcomes After Single-Unit Unrelated Cord Blood Transplantation for Non-Remission Acute Myeloid Leukemia?

Journal: Transplantation and cellular therapy
Published: January 13, 2026

Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.

Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.

Journal: American journal of hematology
Published: November 10, 2025

GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study.

GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study.

Journal: Blood advances
Published: October 01, 2025

GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study.

GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study.

Journal: Blood advances
Published: October 01, 2025

Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients.

Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients.

Journal: British journal of haematology
Published: July 20, 2025

Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype.

Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype.

Journal: International journal of hematology
Published: July 03, 2025

RB and CHASER as induction therapy for transplant-eligible mantle cell lymphoma.

RB and CHASER as induction therapy for transplant-eligible mantle cell lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH
Published: June 29, 2025

Analyses of transplantation outcomes for adult patients with mixed-phenotype acute leukemia.

Analyses of transplantation outcomes for adult patients with mixed-phenotype acute leukemia.

Journal: Blood neoplasia
Published: May 20, 2025
Showing 1-12 of 142

Last Updated: 09/26/2026